| 1 | Denosumab | Denosumab | 1件: D03684D03684 💬 | TNFSF111件: TNFSF11 💬 | Breast cancer7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis | 0467件: 46, 50, 93, 95, 96, 274, 299 💬 | 
| 2 | Denosumab - - immunoglobulin g2 human monoclonal antibody to rank ligand | Denosumab | 1件: D03684D03684 💬 | TNFSF111件: TNFSF11 💬 | Breast cancer7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis | 2741件: 274 💬 | 
| 3 | Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand | Denosumab | 1件: D03684D03684 💬 | TNFSF111件: TNFSF11 💬 | Breast cancer7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis | 2741件: 274 💬 | 
| 4 | Pralia 60 mg subcutaneous injection syringe(denosumab) | Denosumab | 1件: D03684D03684 💬 | TNFSF111件: TNFSF11 💬 | Breast cancer7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis | 0461件: 46 💬 | 
| 5 | Pralia 60mg subcutaneous injection syringe(denosumab) | Denosumab | 1件: D03684D03684 💬 | TNFSF111件: TNFSF11 💬 | Breast cancer7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis | 0461件: 46 💬 | 
| 6 | Prolia | - | - | - | - | 2741件: 274 💬 |